NCT04423744

Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants

Randomized, Single-blind, Double-dummy, 4-fold Cross-over, Placebo- and Active-controlled Study to Investigate the Influence of BAY 1817080 on the QTc Interval in Healthy Male and Female Participants (TQT Study)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

In this study, researchers want to find whether the study drug BAY1817080 has an effect on the electrocardiogram (ECG). 40 healthy male or female participants with the age of 18 to 65 years will be enrolled into this study. The ECG of the participants will be monitored closely by the researchers to detect any change after intake of the study medication.

Conditions

• Cough
• Endometriosis
• Overactive Bladder

Interventions

Type	Name	Description
DRUG	BAY1817080	Film-coated tablet
DRUG	Moxifloxacin	Film-coated tablet
DRUG	Placebo	Matched placebo as film-coated tablet

Timeline

• Start date: 2020-06-18
• Primary completion: 2020-11-09
• Completion: 2021-01-21
• First posted: 2020-06-09
• Last updated: 2022-01-24

Locations

1 site across 1 country: Germany